These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9389990)

  • 1. Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis.
    van der Lely AJ; de Herder WW; Janssen JA; Lamberts SW
    J Endocrinol; 1997 Oct; 155 Suppl 1():S9-13; discussion S15-6. PubMed ID: 9389990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
    Wass JA
    J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
    Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
    Thissen JP; Ketelslegers JM; Maiter D
    Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly.
    Sneppen SB; Lange M; Pedersen LM; Kristensen L LØ; Main KM; Juul A; Skakkebaek NE; Feldt-Rasmussen U
    Growth Horm IGF Res; 2001 Dec; 11(6):384-91. PubMed ID: 11914026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
    Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
    Grinspoon S; Clemmons D; Swearingen B; Klibanski A
    J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction.
    Reeves I; Abribat T; Laramee P; Jasmin G; Brazeau P
    Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study.
    Dutta P; Singhal S; Sachdeva NK; Shah VN; Pathak A; Mukherjee KK; Bhansali A
    J Assoc Physicians India; 2014 Aug; 62(8):686-90. PubMed ID: 25856936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.